Garland Kgosi More | Pharmacology | Best Researcher Award

Dr. Garland Kgosi More | Pharmacology | Best Researcher Award

Dr. Garland Kgosi More, University of South Africa, South Africa

Dr. Garland Kgosi More is a distinguished agricultural scientist specializing in medicinal plant research, particularly in combating infectious diseases. With a PhD in Agriculture from the University of South Africa (UNISA) and a Master’s in Medicinal Plant Sciences from the University of Pretoria (UP), he has made significant contributions to antiviral, antimicrobial, and phytochemical studies. His groundbreaking research on in vitro anti-Rift Valley Fever Virus and medicinal plant metabolomics has earned him international recognition. Currently, Dr. More serves as a Chief Laboratory Technologist and Senior Lecturer at UNISA, contributing to academic excellence through teaching, supervision, and extensive research. His work is widely published in esteemed journals, and he actively mentors postgraduate students. He is passionate about using indigenous knowledge for modern therapeutic solutions and continues to advance global health through innovative scientific inquiry. 🌿🧬

Publication Profile

scopus

Orcid

Google Scholar

🎓 Education

Dr. Garland Kgosi More earned his Doctor of Philosophy in Agriculture from UNISA in 2021, specializing in in vitro anti-Rift Valley Fever Virus research using 1H-NMR metabolomics. His Master of Science in Medicinal Plant Sciences from UP, awarded with distinction in 2013, focused on the antimicrobial constituents of Artemisia afra against periodontal pathogens. In 2007, he completed his Bachelor of Science Honours in Botany, exploring the antimicrobial properties of medicinal plants targeting oral microorganisms. Prior to this, he obtained a Bachelor of Science in Natural/Biological Sciences from UP in 2006, majoring in Botany and Zoology. Committed to professional development, he pursued certifications in Project Management (2020), Hazardous Chemical Substance Handling (2012), HIV/AIDS Awareness (2009), and Occupational Health and Safety Legislation (2008). His interdisciplinary education has equipped him with a robust foundation in agricultural research, biotechnology, and medicinal plant pharmacology. 🧪🌱

💼 Experience

Dr. Garland Kgosi More has over 15 years of academic and research experience. Currently serving as Chief Laboratory Technologist and Senior Lecturer at UNISA, he provides technical expertise, leads laboratory operations, supervises postgraduate students, and conducts high-impact research. He previously held positions as a Laboratory Technologist at UNISA (2014–2023) and Laboratory Technician at UP (2008–2014). In these roles, he managed high-containment laboratories, implemented safety protocols, and supported undergraduate and postgraduate research. His extensive experience includes research project management, laboratory quality control, and the development of standard operating procedures. He has also contributed to health and safety compliance, waste management, and the application of advanced analytical techniques like NMR and UHPLC-MS. Beyond academia, Dr. More actively engages in community outreach projects, promoting scientific knowledge and empowering emerging researchers. His leadership and dedication have significantly advanced agricultural and medicinal plant research. 🧬📊

🏅 Awards and Honors

Dr. Garland Kgosi More has been recognized for his outstanding contributions to agricultural and medicinal plant sciences. His achievements include publishing in prestigious journals like Scientific Reports, Viruses, and MDPI Antioxidants. His doctoral research on antiviral compounds using NMR metabolomics has earned international acclaim. He has received accolades for mentoring postgraduate students and contributing to their successful research publications. Dr. More has served on academic committees, peer-reviewed journals, and research councils, demonstrating academic leadership. He has also presented at numerous international conferences, sharing insights on medicinal plant pharmacology and disease management. His collaborations with multidisciplinary researchers globally further highlight his dedication to scientific advancement. Committed to public health, he has supported projects addressing infectious diseases like HIV and tuberculosis. Dr. More’s accolades exemplify his unwavering commitment to research excellence and societal impact. 🏆🌿

🔎 Research Focus

Dr. Garland Kgosi More’s research revolves around agricultural biotechnology, phytochemistry, and medicinal plant sciences. His primary focus is the identification and analysis of bioactive compounds from medicinal plants for antiviral, antimicrobial, and anti-inflammatory applications. Using advanced metabolomics, including 1H-NMR and UHPLC-MS, he investigates the therapeutic potential of indigenous South African flora. His studies on antiviral agents against the Rift Valley Fever Virus and antimicrobial properties of Artemisia afra have made significant strides in infectious disease management. Additionally, he explores nanotechnology applications in plant-based drug development and investigates the pharmacological effects of nanoparticles synthesized from plant extracts. His multidisciplinary approach includes in silico modeling, molecular docking studies, and cytotoxicity evaluations. Through his extensive research, Dr. More aims to bridge traditional medicine with modern pharmacology, contributing to the discovery of innovative treatments for viral infections and antimicrobial resistance. 🌿🔬

Publication Top Notes

📚 Antimicrobial activity of medicinal plants against oral microorganismsCited by 242, 2008 🦷🌿
📚 In-vitro analysis of free radical scavenging activities and suppression of LPS-induced ROS production in macrophage cells by Solanum sisymbriifolium extractsCited by 119, 2020 🧪🛡️
📚 Antimicrobial Constituents of Artemisia afra Jacq. ex Willd. against Periodontal PathogensCited by 83, 2012 🌿🦷
📚 Novel silver-platinum bimetallic nanoalloy synthesized from Vernonia mespilifolia extract: Antioxidant, antimicrobial, and cytotoxic activitiesCited by 64, 2020 🧬🦠
📚 Antimicrobial, antioxidant, and cytotoxic properties of biosynthesized copper oxide nanoparticles (CuO-NPs) using Athrixia phylicoides DCCited by 46, 2023 🧪🦠
📚 Alkaloids from aerial parts of Annona senegalensis against Streptococcus mutansCited by 41, 2017 🌿🧬
📚 A review of the ethnopharmacology, phytochemistry and pharmacological relevance of the South African weed Solanum sisymbriifolium Lam. (Solanaceae)Cited by 29, 2019 📖🌱
📚 Synthesis of furocoumarin–stilbene hybrids as potential multifunctional drugs against multiple biochemical targets associated with Alzheimer’s diseaseCited by 23, 2020 🧠💊
📚 Metabolomic profile of medicinal plants with anti-RVFV activityCited by 19, 2022 🦠🧬
📚 Metabolomic Profiling of Antioxidant Compounds in Five Vachellia SpeciesCited by 18, 2021 🌳🛡️
📚 In vitro evaluation of anti-Rift Valley Fever Virus, antioxidant and anti-inflammatory activity of South African medicinal plant extractsCited by 18, 2021 🦠🧪
📚 Lithium inhibits NF-κB nuclear translocation and modulates inflammation profiles in Rift Valley Fever virus-infected Raw 264.7 macrophagesCited by 16, 2021 🧫🛡️
📚 Bio-synthesized calcium carbonate (CaCO3) nanoparticles: Their anti-fungal properties and application as nanofertilizer on Lycopersicon esculentum growth and gas exchangeCited by 14, 2023 🍅🌿
📚 Design, synthesis and evaluation of the 2′-hydroxy-3′-iodo-5′-nitrochalcones for cytotoxicity (MCF-7 & A549) and potential to inhibit tyrosine kinase (VEGFR-2) activityCited by 12, 2024 🧪🧬
📚 Antimicrobial, cytotoxic and oxidative stress inhibitory activities of terpenoids and flavonols from Senegalia nigrescens (Oliv.) PJH HurterCited by 9, 2021 🌿🧫

Conclusion 🏆

Dr. Garland Kgosi More is a highly suitable candidate for the Best Researcher Award. His exceptional academic background, impactful research in antiviral and antimicrobial compounds, significant publication record, commitment to student mentorship, and leadership in scientific research position him as a strong contender for this prestigious recognition.

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Prof Hatice Yesim Karasulu, Ege University, Turkey

Prof. Dr. Hatice Yesim Karasulu is a renowned pharmaceutical technology expert at Ege University, Turkey. With a Ph.D. in Pharmaceutical Technology, she became an Associate Professor in 2006 and a Professor in 2011. She is a consultant at Ege University’s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems like liposomes, nanoparticles, and emulsions. She has over 50 publications, 2 patents, and several industry collaborations. Additionally, she has authored multiple book chapters and received various grants. 🌍💊📚🔬💡

Publication Profile

google scholar

Academic and Professional Background

Prof. Dr. Hatice Yesim Karasulu is a renowned academic and consultant in pharmaceutical technology. With a Ph.D. from the University of Ege, she became an Associate Professor in 2006 and a Professor in 2011. She currently consults at Ege University’s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems such as liposomes and nano/microparticles. She has published over 50 papers, authored five book chapters, and holds two patents related to nano-drug delivery systems. Her collaborative projects with universities and the pharmaceutical industry aim to innovate drug delivery. 🧪📚

Research and Innovations

Prof. Hatice Yesim has conducted extensive research on drug delivery systems, particularly through EU and TUBITAK-funded projects. Her studies focus on the development of microemulsion formulations, bioadhesive systems, and surfactant effects for enhanced drug bioavailability. Notable projects include investigations on skin absorption, nasal drug diffusion, and the creation of transdermal systems for various drugs such as naproxen and terbutaline sulphate. Additionally, Prof. Yesim has explored the use of PEG-PLA-PGA triblock micelles for cancer treatments and innovative dry powder inhalers for asthma management. Her work contributes significantly to improving drug delivery technologies for targeted therapies. 🌟👩‍🔬

Books and Patents

Prof. Hatice Yesim Karasulu is a distinguished academic and researcher, known for her contributions to pharmaceutical sciences. As an author of several influential book chapters, she has published with leading publishers like Elsevier, Taylor & Francis, and InTech. Prof. Karasulu holds multiple patents, including innovative nano-drug delivery systems, with both national and international applications. Her work exemplifies a seamless integration of cutting-edge research and practical solutions, especially in the pharmaceutical industry. Her contributions continue to impact the development of new drug delivery technologies. 📚💡💊🌍

Industry Projects

Prof. Hatice Yesim’s research focuses on the development of products aimed at improving the quality of life for psoriasis patients. Her work involves conducting clinical trials and preparing submissions for approval, such as those to the Ministry of Health in CTD format. The primary goal of her research is to create effective solutions for managing psoriasis, a chronic skin condition, and to enhance patient outcomes through innovative treatments. This aligns with areas of dermatology, clinical trials, and health innovation. Her research significantly contributes to improving patient care and advancing medical treatments for dermatological conditions. 🧴🩺💊🧑‍🔬

Research Focus

Prof. Hatice Yesim Karasulu’s research focuses on pharmaceutical formulations and drug delivery systems, with a particular emphasis on transdermal delivery, microemulsions, and lipophilic microspheres. Her work explores the skin permeation, anti-inflammatory effects, and analgesic properties of various formulations like diclofenac sodium and naproxen. She has also studied the toxicity, stability, and applications of microemulsions as novel drug carriers. Additionally, her research includes the pharmacokinetics of drugs, modeling drug release, and the use of bioadhesive formulations in vaginal and nasal drug delivery systems. 💊📦💉💡🌱

Publication Top Notes

Transdermal delivery of diclofenac sodium through rat skin from various formulations

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations

Microemulsions as novel drug carriers: the formation, stability, applications and toxicity

Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies

Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates

Modeling of theophylline release from different geometrical erodible tablets

Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans

 

 

Shubham Sharma | Pharmacology | Best Researcher Award

Shubham Sharma | Pharmacology | Best Researcher Award

Dr Shubham Sharma, Pfizer, United States

Dr. Shubham Sharma is a leading computational modeler with 8+ years of expertise in theoretical materials science, physics, and chemistry. Holding a Ph.D. in Chemical & Environmental Engineering from Brown University (2021), he specializes in atomistic modeling and solid-form design, notably working at Pfizer where he leads drug de-risking efforts. His research in catalysis, electrochemistry, and crystal structure predictions has earned him over 10 Pfizer Bravo awards. Dr. Sharma’s groundbreaking work is recognized globally, including invited talks at major conferences, advancing both pharmaceutical and renewable energy applications. 💻🔬💊⚡

Publication Profile

Google Scholar

Education

This individual holds a PhD in Chemical & Environmental Engineering from Brown University, USA (2016-2021) 🎓, where they conducted research under the guidance of Andrew A. Peterson 🧑‍🔬. Their academic journey began with a Bachelor of Technology (B. Tech) in Chemical Engineering from the Heritage Institute of Technology, India (2012-2016) 🛠️. With a strong foundation in chemical engineering, they have pursued advanced studies focusing on environmental solutions and sustainability 🌍. Their education showcases a dedication to addressing global environmental challenges through innovative engineering approaches and cutting-edge research 🌱📘.

Work Experience

Currently serving as a Senior Scientist in Computational Materials Science at Pfizer Inc. (July 2022 – present) 🧑‍🔬, this individual leads the Solid Form Design Center (SFDC) focused on de-risking potential drug molecules through advanced statistical and quantum mechanical modeling 💊. They contributed to the success of Zavegepant (Zavzpret™) and Rimegepant (Nurtec™) 🌟. As a core member of the Crystal Structure Prediction team, they specialize in electronic structure theory, density functional theory, and atomistic modeling 🧬. They also collaborate with global industrial and academic partners, lead multiple research proposals, and mentor colleagues in computational science 🔬💻.

Selected conference presentations

Sharma has delivered numerous invited talks and presentations globally 🌍. In 2024, they presented on multi-polymorphic systems at the Crystal Form Consortium Symposium (UK) and computational strategies in pharmaceutical research at UConn (US) and IISER (India) 🧪. Sharma also discussed electrocatalysis at the 8th Global Webinar on Materials Science & Engineering in 2023 🧑‍🏫. Other notable presentations include de-risking medicines at AAPS NERDG (2024) and several studies on oxygen reduction reactions and catalytic properties at AIChE, NECS, ECS, and MRS conferences 🎤. Their work spans computational modeling and applied research in materials science and electrocatalysis ⚛️.

Research Focus

The research focus of Sharma spans electrochemistry, catalysis, and materials science. Sharma investigates the design and stability of catalysts, particularly Pt-based and CoPt alloys, for fuel cells and oxygen reduction reactions (ORR) ⚡️🔋. His work includes dynamic stability, reaction barriers, and potential-controlled reactions, using advanced techniques like density functional theory (DFT) and experimental-theoretical integration. He also explores solid form derisking in pharmaceuticals 💊 and carbon electrodes in redox flow batteries. Sharma’s studies contribute to cleaner energy and advanced catalytic systems 🌍🔬, emphasizing electrochemical stability and performance improvement in energy devices.

 

Publication Top Notes

Hard-magnet L10-CoPt nanoparticles advance fuel cell catalysis

Anisotropic Strain Tuning of L10 Ternary Nanoparticles for Oxygen Reduction

Face-centered tetragonal (FCT) Fe and Co alloys of Pt as catalysts for the oxygen reduction reaction (ORR): A DFT study

Ordered CoPt oxygen reduction catalyst with high performance and durability

Metal dissolution from first principles: Potential-dependent kinetics and charge transfer

Assessment of carbon monoxide exposure in roadside food-vending shanties using coal cookstoves in Kolkata, India

Dynamic stability of Pt-based alloys for fuel-cell catalysts calculated from atomistics

Conclusion

Dr. Shubham Sharma’s innovative research in computational modeling and materials science, alongside his leadership in both academic and industrial collaborations, makes him an exceptional candidate for the Best Researcher Award. His contributions have not only advanced pharmaceutical drug design but also impacted renewable energy research, marking him as a distinguished leader in his field.

Divya Jain | Pharmacology Award | Women Researcher Award

Dr. Divya Jain | Pharmacology Award | Women Researcher Award

Dr. Divya Jain, Uttaranchal University, India

Dr. Divya Jain is an accomplished microbiologist, holding a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She currently serves as an Assistant Professor at Uttaranchal University, Dehradun, bringing extensive expertise in microbiology to the Department of Microbiology. Her previous roles include an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology in Chandigarh. Dr. Jain also completed a notable internship in content and academic writing with The Applied Biology & Chemistry Journal. 📚🔬✨

Publication profile

Orcid

Google Scholar

🎓 Education

Dr. Divya Jain holds a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She completed her high school education in PCB from S.D.R.R Public School, Shamli (2013). 📘🔬

🏢 Work Experience

Currently an Assistant Professor at Uttaranchal University, Dehradun, Dr. Jain also served as an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology, Chandigarh. 📚🔬

🏅 Certificates and Awards

Dr. Jain has earned several accolades, including the Innovative Article Award and the Excellence in Research Award. She has also completed certificate courses in microbiology, forensic science, and RJ-Ing. 🏆📜

 

Research Focus 🔬🌍

Dr. Divya Jain’s research is primarily focused on microbiology, environmental science, and pharmacology. Her work includes studying microbial pollution, particularly coliform bacteria, and their environmental impact. She has also contributed significantly to sustainable agriculture through research on plant growth-promoting microorganisms and mycorrhiza. Dr. Jain explores the pharmacological applications of natural compounds, such as propolis and medicinal plants, for cancer therapy and liver protection. Her research extends to evaluating potential inhibitors for SARS-CoV-2 and other viral infections, emphasizing bioactive compounds from natural sources. Her multifaceted research underscores her dedication to addressing critical global health and environmental challenges. 🌱🧬🧪

 

Publication Top Notes

  • “Microbial pollution of water with special reference to coliform bacteria and their nexus with environment” 🌊🦠 (110 citations, 2021)
    S Some, R Mondal, D Mitra, D Jain, D Verma, S Das
    Energy Nexus 1, 100008
  • “Role of mycorrhiza and its associated bacteria on plant growth promotion and nutrient management in sustainable agriculture” 🌱🔬 (90 citations, 2020)
    D Mitra, N Uniyal, P Panneerselvam, A Senapati, AN Ganeshamurthy
    International Journal of Life Sciences and Applied Sciences 1 (1), 1-1
  • “Propolis: An update on its chemistry and pharmacological applications” 🍯⚗️ (73 citations, 2022)
    R Hossain, C Quispe, RA Khan, ASM Saikat, P Ray, D Ongalbek, …
    Chinese medicine 17 (1), 100
  • “Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis” 🚬🔬 (53 citations, 2021)
    D Jain, P Chaudhary, N Varshney, KS Bin Razzak, D Verma, …
    Journal of Oncology 2021 (1), 5905357
  • “Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components” 🧬🌿 (44 citations, 2021)
    D Verma, D Mitra, M Paul, P Chaudhary, A Kamboj, H Thatoi, P Janmeda, …
    Current Research in Pharmacology and Drug Discovery 2, 100038
  • “Biosynthesis of secondary metabolites based on the regulation of microRNAs” 🧬🧪 (33 citations, 2022)
    R Hossain, C Quispe, ASM Saikat, D Jain, A Habib, P Janmeda, MT Islam, …
    BioMed Research International 2022 (1), 9349897
  • “Hepatoprotective activity of medicinal plants: A mini review” 🌿🛡️ (29 citations, 2020)
    D Jain, P Chaudhary, A Kotnala, R Hossain, K Bisht, MN Hossain
    Journal of Medicinal Plants Studies 8 (5), 183-188
  • “Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABAA and GABAB Receptor Interaction Pathway” 💤🍊 (25 citations, 2021)
    R Hossain, K Al-Khafaji, RA Khan, C Sarkar, MS Islam, D Dey, D Jain, …
    Pharmaceuticals 14 (8), 721
  • “Anticancer effects of acteoside: Mechanistic insights and therapeutic status” 🧬🎗️ (22 citations, 2022)
    RA Khan, R Hossain, P Roy, D Jain, ASM Saikat, APR Shuvo, M Akram, …
    European Journal of Pharmacology 916, 174699
  • “Carcinogenic effects of N-nitroso compounds in environment” 🚫🦠 (22 citations, 2020)
    D Jain, P Chaudhary, N Varshney, P Janmeda
    Environment Conservation Journal 21 (3), 25-41